Joanne Lagmay, MD

The participants of this study will be children, adolescents, and young adults with residual osteosarcoma, which cannot be removed completely through surgery. Participants will have achieved a partial response or stable disease at the end of…

Investigator

Joanne Lagmay

Status

Accepting Candidates

Ages

5 Years - 30 Years

Sexes

All

This is a prospective, multicenter clinical trial in subjects with newly diagnosed high-risk neuroblastoma to evaluate the efficacy and safety of administering naxitamab with standard induction therapy. The initial chemotherapy will include 5 cycles…

Investigator

Joanne Lagmay

Status

Accepting Candidates

Ages

12 Months - 21 Years

Sexes

All

This phase 2, open label, single arm study will investigate the use of tazemetostat in patients with recurrent/refractory and/or metastatic malignant peripheral nerve sheath tumors.

Investigator

Joanne Lagmay

Status

Accepting Candidates

Ages

12 Years - 99 Years

Sexes

All